Navigation Links
PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation
Date:11/26/2007

ortion of respirable droplets delivered in the shortest possible period of time. Combined with its silent mode of operation, small size (it fits in the palm of your hand), light weight, and battery use, eFlow helps reduce the burden of taking daily, inhaled treatments.

Aztreonam lysine for inhalation is an investigational therapy and has not yet been determined safe or efficacious in humans.

About Cystic Fibrosis

Today, more than 30,000 people in the United States have CF. CF is a chronic, debilitating genetic disease. A major characteristic of CF is production of abnormally thick, sticky mucus in the lungs, trapping bacteria and predisposing patients to lung infections, which continually damage their lungs.

Pulmonary infection with Gram-negative bacteria, particularly pulmonary P. aeruginosa, represents the single greatest cause of morbidity and mortality among CF patients. Currently there is no known cure for CF, and the goal of CF therapy is to control symptoms and prevent further lung damage.

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

About PARI Pharma

PARI Pharma focuses on the development of aerosol delivery devices and therapies. Based on PARI's 100-year history working with aerosols, PARI Pharma develops treatments for pulmonary and nasal administration optimized to advanced delivery platforms, such as eFlow.

PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and optimization, CMC, analytics, aerosol characterization, clinical protocol development, and regulatory guidance. PARI Pharma has several clinical development programs ongoing, either partnered or on its own. PARI Pharma, a PARI Medical Holding company, is l
'/>"/>

SOURCE PARI Pharma
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
3. Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...DIANAPOLIS, Dec. 1 Roche announced...uate differences in perceived pain and,discomfort...-CHEK blood,glucose monitoring systems and lancin...lts indicated that, overall, the ACCU-CHEK Aviva a...g systems and the ACCU-CHEK Multiclix, ACCU-CHEK,...
(Date:12/1/2008)...YMOUTH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/...nnounced that dosing of subjects has begun in stud...g dose Phase 1b study of trodusquemine (MSI-1436) ... is a novel therapeutic for the treatment of type ...eripherally to regulate insulin and leptin pathway...
(Date:12/1/2008)...N DIEGO, Dec. 1 Vical In...eceipt of a $1.0 million milestone payment from Me...ation of a Phase I clinical trial of an investigat...date vaccine is based on Vical,s DNA gene delivery...ranscriptase (hTERT). hTERT is the subject of sepa...
(Date:11/28/2008)...DIANAPOLIS, Nov. 28 Eli ...s supplemental New Drug Application (sNDA) from,t...balta(R) (duloxetine HCl),for the management of c...on in,the first half of 2009, adding data from a ...oarthritis pain of the knee. , The decision...
Breaking Medicine Technology:Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 1Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 2Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 3Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 4Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 5Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 6Earthjustice EIP Report 3A Dangerous Mercury Pollution From Unregulated Cement Kilns in U S About Twice as High as Levels Previously Projected by EPA 24308 7Spherix Receives NASDAQ Bid Price Deficiency Letter 6686 1Spherix Receives NASDAQ Bid Price Deficiency Letter 6686 2Simple Procedure Improves Male Fertility 24302 1Simple Procedure Improves Male Fertility 24302 2Simple Procedure Improves Male Fertility 24302 3Rock The Cradles Bad Boy Landon Brown Owes His Irresistible New Smile to Dr Michael Kosdon 24297 1Rock The Cradles Bad Boy Landon Brown Owes His Irresistible New Smile to Dr Michael Kosdon 24297 2
...he outcome of many illnesses for which patients ar...mproved dramatically over the past decades, despit...ticated mechanical and pharmacological support of ...nts requiring intensive care for more than five da... morbidity. Recently, however, evidence from a fe...
...linical guidelines from the disciplines of cardiol... emphasized the importance of cardiac markers in d...n. The measurement of cardiac troponins is especi...enting with acute coronary syndrome (ACS) who have...viously considered to have unstable angina are now...
Other Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 2Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 3
(Date:12/1/2008)...UIS, Dec. 2 While many A...omic challenges including rising costs of,basic n...press Scripts,(Nasdaq: ESRX ) has expanded Rx O...prescription medicines. , (Logo: http://w...SLOGO ) , Lower-income consumers can now re...
(Date:12/1/2008)...Diego, December 2, 2008 As the connection between...) became clearer and legislation was passed to red...ced. In an article published in the January 2009 i...ne , researchers from the University of California...olumbia University have recalibrated the CHD Polic...
(Date:12/1/2008)... -- Product Sales More Than Doubled Over Prior...w Company has Streamlined Operations, ... , TSX Venture Exchange: NVC , , RICHM...nc. (TSXV: NVC), a new specialty vascular device c...third quarter and nine months ended September 30, ...
(Date:12/1/2008)...Y, Dec. 1 /PRNewswire-FirstCall/ - The Westaim Cor...ecial meeting of shareholders of NUCRYST Pharmaceu...CRYST shareholders of approximately US$15 million ...iew alternatives to maximize the value of its 74.5...ness Corporations Act, NUCRYST,s Board of Director...
Breaking Medicine News(10 mins):Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 2Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 3Health News:Amid Economic Crisis, Express Scripts Offers Easy and Affordable Way for Lower-Income Consumers to Get Six-Month Supply of Prescription Medicines 4Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 2Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 3Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 4Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 5Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 6Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 7Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 8Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 9Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 10Health News:Neovasc Inc. Reports Third Quarter Fiscal Year 2008 Financial Results 11Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2
...ouncil of New Zealand said that the euthanasia cam...nse for practising medicine in New Zealand. // The...ts about ending their lives. But the Council said ...registered as a doctor to carry out his euthanasia...
...a study by Emory University researcher Chensheng "...tary exposure to two common pesticides used in U.S...stitute normal diets of children with organic food...oncentration of pesticides was reduced to non-dete...
... can be defined as any cereal grain containing all...an layer. It could have been flaked, rolled, crack...it’s still whole so long as it is entire. // The W...ervation Trust came out with a stamp to make it ea...
...iate use of anabolic steroids, more specifically a...e to the stimulation of sebaceous glands. Sebaceou...e sebum into hair follicles and majority of the bo...d to treat facial swelling linked to allergy and t...
Other Medicine News:
...launch of the NCP-2, ACS proudly introduces full d... more tools for assessing the administration of EC...Treatment Report.,The ACS Treatment Report is...at allows both physicians and therapists to review...
...utionary Powerheart AED G3-Automatic simplifies th...a shock button. All that you have to do is attach ... defibrillation pads are attached to the patient, ...zes the rhythm using the patented RHYTHMx software...
...ann Electronic Stethoscope Model 4100WS features a...on (ANR) technology allowing you to reduce ambient...ating critical body sounds. Three frequency modes ...her body sounds: Bell (20-200 Hz), Diaphragm (100-...
...Logic Bone Growth Stimulator is a portable, batter...tive treatment for spinal fusion. The device is wo...etic field treatment to the fusion site. The devic...d, to produce a very low energy signal that is ver...
Medicine Products: